|Articles|June 1, 2001
- Pharmaceutical Executive-06-01-2001
- Volume 0
- Issue 0
Emotion - The New Brand Integrator
Author(s)Gil Bashe
Driven by the quest for innovation, the intensity of competition, and the pressure to create megabrands and megamergers, pharmaceutical executives are exploring an influential force still untapped by most marketing and communication departments-the power of emotion.
Advertisement
Articles in this issue
almost 25 years ago
Industry Under Investigationalmost 25 years ago
Emotion - The New Brand Integratoralmost 25 years ago
For Love of the Gamealmost 25 years ago
Field of Dreamsalmost 25 years ago
Workshop: Access Optionsalmost 25 years ago
Rx-to-OTC: Unwanted Attentionalmost 25 years ago
Emotion - Biotech Renaissance Manalmost 25 years ago
Relocation: Coming to Americaalmost 25 years ago
Stocks: Catching the Market Bluesalmost 25 years ago
Gathering LightAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Does FDA's Shift From Two Pivotal Trials to One Represent a Genuine Evolution?
2
The Biotech Industry’s Relationship with Real-Time Data: Q&A with Dr. Richard Graham
3
The Evolving Relationship Between FDA and Biotech
4
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
5